Radiopharma on the rise: Are supply chains ready?

Learn how specialized logistics and end-to-end orchestration help ensure treatments arrive on time, on temperature, and fully compliant. With short half-lives and fragmented regulations across borders, there’s no margin for error with radiopharmaceutical logistics. We spoke to World Courier’s Marco Hogenboom to discuss the critical challenges for this rapidly growing market and why World Courier’s fully in-house, end-to-end logistics model is a key benefit for radiopharma sponsors. Radiopharmaceutical therapies are rapidly becoming mainstream in oncology. Credit via Shutterstock Radiopharmaceutical therapies are moving from niche innovation to a mainstream oncology option. For supply chains built around stable, mass-produced medicines, radiopharma introduces…

Source: Clinical Trials Arena